Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

DNA Copy Number Aberrations, and Human Papillomavirus Status in Penile Carcinoma. Clinico-Pathological Correlations and Potential Driver Genes
Susannah La-Touche, Christophe Lemetre, Maryou B. Lambros, et al.
PLoS ONE (2016) Vol. 11, Iss. 2, pp. e0146740-e0146740
Open Access | Times Cited: 21

Showing 21 citing articles:

Penile cancer epidemiology and risk factors
Antoin Douglawi, Timothy A. Masterson
Current Opinion in Urology (2018) Vol. 29, Iss. 2, pp. 145-149
Closed Access | Times Cited: 95
Immune-based therapies in penile cancer
Vidhu B. Joshi, Philippe E. Spiess, Andrea Necchi, et al.
Nature Reviews Urology (2022) Vol. 19, Iss. 8, pp. 457-474
Open Access | Times Cited: 43
Therapeutic Potential of Targeting the SUMO Pathway in Cancer
Antti Kukkula, Veera K. Ojala, Lourdes M. Mendez, et al.
Cancers (2021) Vol. 13, Iss. 17, pp. 4402-4402
Open Access | Times Cited: 49
An update on treatment of penile cancer
Juskaran Chadha, Jad Chahoud, Philippe E. Spiess
Therapeutic Advances in Medical Oncology (2022) Vol. 14
Open Access | Times Cited: 37
Copy number amplification and SP1-activated lncRNA MELTF-AS1 regulates tumorigenesis by driving phase separation of YBX1 to activate ANXA8 in non-small cell lung cancer
Xiyi Lu, Jing Wang, Wei Wang, et al.
Oncogene (2022) Vol. 41, Iss. 23, pp. 3222-3238
Closed Access | Times Cited: 33
The molecular pathogenesis of penile carcinoma—current developments and understanding
Anthony Emmanuel, Jeremy Nettleton, Nick Watkin, et al.
Virchows Archiv (2019) Vol. 475, Iss. 4, pp. 397-405
Closed Access | Times Cited: 40
Genetics and penile cancer
Jad Chahoud, Curtis R. Pickering, Curtis A. Pettaway
Current Opinion in Urology (2019) Vol. 29, Iss. 4, pp. 364-370
Closed Access | Times Cited: 32
Retrospective clinical and molecular characterisation of patients with penile intraepithelial neoplasia
Sara K. Elbæk, Philippe Lamy, Sofie Laugesen, et al.
BJU International (2025)
Open Access
Genomic profiling reveals the pivotal role of hrHPV driving copy number and gene expression alterations, including mRNA downregulation of TP53 and RB1 in penile cancer
Juliana Melo Macedo, Elis Vanessa de Lima Silva, Leudivan Ribeiro Nogueira, et al.
Molecular Carcinogenesis (2020) Vol. 59, Iss. 6, pp. 604-617
Closed Access | Times Cited: 26
Current management and future perspectives of penile cancer: An updated review
Florent Peyraud, C. Allenet, Marine Gross‐Goupil, et al.
Cancer Treatment Reviews (2020) Vol. 90, pp. 102087-102087
Open Access | Times Cited: 26
Analysis of the PI3K-AKT-mTOR pathway in penile cancer: evaluation of a therapeutically targetable pathway
Anthony Adimonye, Elzbieta Stankiewicz, Sakunthala C. Kudahetti, et al.
Oncotarget (2018) Vol. 9, Iss. 22, pp. 16074-16086
Open Access | Times Cited: 19
Penile cancer: Updates in systemic therapy
Vidhu B. Joshi, Juskaran Chadha, Jad Chahoud
Asian journal of urology (2022) Vol. 9, Iss. 4, pp. 374-388
Open Access | Times Cited: 11
Innovative systemic therapies for penile cancer
Jad Chahoud, Rachel Pham, Guru Sonpavde
Current Opinion in Urology (2021) Vol. 32, Iss. 1, pp. 8-16
Closed Access | Times Cited: 11
Risk factors and molecular characterization of penile cancer: impact on prognosis and potential targets for systemic therapy
Anita Thomas, Joren Vanthoor, Gigi Vos, et al.
Current Opinion in Urology (2019) Vol. 30, Iss. 2, pp. 202-207
Closed Access | Times Cited: 11
HPV-associated penile cancer: Impact of copy number alterations in miRNA/mRNA interactions and potential druggable targets
Jenilson da Silva, Leudivan Ribeiro Nogueira, Ronald Wagner Pereira Coelho, et al.
Cancer Biomarkers (2021) Vol. 32, Iss. 2, pp. 147-160
Closed Access | Times Cited: 9
Future directions in advanced penile cancer – mechanisms of carcinogenesis and a search for targeted therapy
Jiasian Teh, Ellen O’Connor, Jonathon J. O’Brien, et al.
Future Oncology (2020) Vol. 16, Iss. 29, pp. 2357-2369
Closed Access | Times Cited: 7
PIK3CA copy number aberration and activation of the PI3K-AKT-mTOR pathway in varied disease states of penile cancer
Anthony Adimonye, Elzbieta Stankiewicz, Susannah La-Touche, et al.
PLoS ONE (2018) Vol. 13, Iss. 6, pp. e0198905-e0198905
Open Access | Times Cited: 6
Systemic treatment of penile squamous cell carcinoma—hurdles and hopes of preclinical models and clinical regimens: a narrative review
Anita Thomas, Luísa Matos do Canto, Cláudia Aparecida Rainho, et al.
Translational Andrology and Urology (2021) Vol. 10, Iss. 10, pp. 4085-4098
Open Access | Times Cited: 6
The Prognostic Value of PIK3CA Copy Number Gain in Penile Cancer
Anthony Adimonye, Elzbieta Stankiewicz, S. La Touche, et al.
Urology (2018)
Closed Access | Times Cited: 5
Human Papilloma Virus, Histopathological, and Molecular Subtyping in Penile Cancer: Relevance for Prognosis and Therapy
Kerstin Junker, Sebastian Hölters, Arndt Hartmann
European Urology Supplements (2017) Vol. 16, Iss. 12, pp. 295-300
Closed Access | Times Cited: 3
Correlação da expressão de microRNAs através da varredura por microarray e de seus alvos preditos com a carcinogênese e o prognóstico do carcinoma espinocelular peniano
Cláudio Bovolenta Murta
(2022)
Open Access
Page 1

Scroll to top